Oncology
News
Diagnostic Challenge: Cutaneous Colon Cancer
News
Eli Lilly Suspends Phase III Trial of Tasisulam for Melanoma
News
Women's Health Initiative: New Findings on Big-Three Cancer Rates
News
Video Report: Many Women Don't Get Recommended Mammograms
News
PFS Rises Fourfold With Afatinib in Select Patients
Major Finding: Median progression-free survival was 1 month with placebo vs. 4.4 months with afatinib in a subgroup of patients most likely to...
News
Denosumab Update Shows 5-Month Advantage in Advanced Breast Cancer
Major Finding: Median time to the first on-study skeletal-related event, such as fracture, spinal cord compression, or radiotherapy or surgery to...
News
Ara-C Prolongs Time to Treatment Failure in Mantle Cell Lymphoma
Major Finding: A conditioning regimen of R-CHOP alternating with R-DHAP and high dose cytarabine followed by stem-cell transplant improved time to...
News
Bevacizumab Short of Mark in First Neoadjuvant Breast Cancer Trial
Major Finding: Pathological complete response overall did not differ significantly at 15% in woman treated with neoadjuvant chemotherapy alone and...
News
Trastuzumab/Pertuzumab Doublet Eradicates Some Early Breast Cancer
Major Finding: Pathologic complete response at the time of surgery was 46% with the pertuzumab (Herceptin)/ trastuzumab/docetaxel combination,...
News
Double Cord Blood Transplant Better Than Single in Acute Leukemia
Major Finding: Transplants of two units of cord blood pushed the 2-year leukemia-free survival rate to 53% vs.
News
Obesity Linked to Worse Outcomes in Common Breast Cancer Subtype
Major Finding: Obese women with hormone receptor–positive, HER2-negative disease were 23% more likely to experience recurrence (P = .035) and had...